• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 406

Substance: 1,4-α-glucan branching enzyme preparation from Bacillus subtilis strain 168 expressing the glucan branching enzyme gene from Aquifex aeolicus strain VF5
Intended Use: As an enzyme in the production of cyclic dextran and enzymatically-synthesized glycogen
Basis: Scientific procedures
Notifier: Ezaki Glico Co., Ltd.
4-6-5, Utajima Nishioyogogawa
Date of filing: Oct 11, 2011
GRAS Notice (releasable information): 406
Date of closure / FDA's Letter: Sep 11, 2012
FDA has no questions
Notes: Corrected letter issued Nov. 1, 2012